Vitamin C for sepsis: Questions remain.

Fujii, Tomoko; Udy, Andrew A; Lankadeva, Yugeesh R

Fujii, Tomoko; Udy, Andrew A; Lankadeva, Yugeesh R.

Afiliación

Fujii T; Intensive Care Unit, Jikei University Hospital, Tokyo, Japan; Australian and New Zealand Intensive Care Research Centre, Monash University School of Public Health and Preventive Medicine, Melbourne, VIC, Australia. Electronic address: tofujii-tky@umin.net.
Udy AA; Australian and New Zealand Intensive Care Research Centre, Monash University School of Public Health and Preventive Medicine, Melbourne, VIC, Australia; Department of Intensive Care & Hyperbaric Medicine, The Alfred, Melbourne, VIC, Australia.
Lankadeva YR; Department of Critical Care, University of Melbourne, Melbourne, VIC, Australia; Preclinical Critical Care Unit, Florey Institute of Neuroscience and Mental Health, Melbourne, Melbourne, VIC, Australia.

Anaesth Crit Care Pain Med ; 41(6): 101151, 2022 12.

Article en En | MEDLINE | ID: mdl-36075562

Asunto(s)

Ácido Ascórbico; Sepsis; Humanos; Ácido Ascórbico/uso terapéutico; Vitaminas; Sepsis/tratamiento farmacológico

Palabras clave

LOVIT trial; Sepsis; Vitamin C

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ácido Ascórbico / Sepsis Límite: Humans Idioma: En Revista: Anaesth Crit Care Pain Med Año: 2022 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google